kentucky glp-1 stomach paralysis lawsuit Novo Nordisk sues Eli Lilly for false advertising over weight loss drug comparisons. Get the details glp-1 nausea class action in

Users who rely solely on the medication for weight reduction risk a condition sometimes referred to as "sarcopenic obesity," where weight is low or normal, but muscle mass is dangerously insufficient

Check the full article for detailed dosing charts and practical tips for managing treatment

Traditionally, kidneys have not been the first organs people think about when discussing obesity or diabetes medications

Multifactorial intervention to reduce cardiorenal disease in type 1 diabetes a prospective, randomised, open, multicenter study the Steno 1 study)

Treatment cycles generally span four to eight weeks, depending on the condition